Wellcome Sanger Institute and COG-UK receive £12.2M UK Government investment for COVID-19 real-time genomic surveillance system
Institute researchers will support the COVID-19 Genomics UK consortium's work by providing high-throughput virus genome sequencing, creating surveillance software to help detect local outbreaks faster, and monitoring for viral mutations that might enable escape from vaccines
The Department for Health and Social Care Testing Innovation Fund has backed the Wellcome Sanger Institute and the COVID-19 Genomics UK (COG-UK) Consortium in expanding whole genome sequencing of positive SARS-CoV-2 virus samples to map how COVID-19 spreads and evolves. The £12.2M funding will facilitate the Sanger Institute’s contribution to building a national real-time genomic surveillance system of COVID-19 to help tackle the pandemic.
As part of the genomic surveillance system, researchers at the Wellcome Sanger Institute are creating surveillance software to help public health authorities detect and respond to local outbreaks faster, monitor for viral mutations associated with escape from vaccines once they are deployed, and support the diverse science and public health aims of the COG-UK Consortium.
Viral genome sequencing data generated across the COG-UK network, including the Wellcome Sanger Institute, is integrated with data from the four UK Public Health Agencies and NHS Test and Trace to help understand outbreaks and strengthen infection control measures.
Since March 2020, COG-UK has generated and made publicly available more than 100,000 SARS-CoV-2 genomes, making up over 45 per cent of the global total. This unprecedented effort has not been achieved previously for any pathogen, anywhere in the world.
The Sanger Institute has been using its funding from Wellcome for its SARS-CoV-2 sequencing and is the largest genome sequencing hub within the COG-UK consortium. As part of the effort, the Institute rapidly established new high-throughput sequencing pipelines and developed supporting software to sequence and analyse positive SARS-CoV-2 virus samples.
Collectively these data and tools have provided important scientific insights into the spread and evolution of the virus, at local, regional, national and international scales.
However, the current second wave of COVID-19 cases in the UK and throughout Europe means that it is more important than ever that genomic tracking of the virus is supported for the long term. The genomic data will be used in genomic surveillance of the virus as new vaccines are deployed, to determine whether the virus evolves to escape them.
“Our mission is to build a national real-time genomic surveillance system for COVID-19. Using genomics to track the SARS-CoV-2 virus in real time will help public health authorities detect and respond to local outbreaks faster and show us how the virus responds when new vaccines are introduced. This new genomic surveillance system will only be possible through sequencing viral genomes at huge scale, thanks to the monumental efforts of scientists at the Wellcome Sanger Institute and across the whole COG-UK network.”
Professor Sir Mike Stratton, Director of the Wellcome Sanger Institute
“To fully understand the spread and evolution of the SARS-CoV-2 virus, we must sequence and analyse the viral genomes. The pattern of accumulation of mutations in the genomes enables us to determine the relatedness of virus samples and define viral lineages in order to understand whether local outbreaks are caused by transmission of single or multiple viral lineages. Analysis of viral genome sequences also allow us to monitor the evolution of SARS-CoV-2 and assess whether specific mutations influence transmission, disease severity, or the impact of interventions such as vaccines.”
Professor Sharon Peacock, who is the Director of the COVID-19 Genomics UK (COG-UK) Consortium, Professor of Public Health and Microbiology at the University of Cambridge and a Director of Science (Pathogen Genomics) at Public Health England
The Wellcome Sanger Institute, with COG-UK, the four UK Public Health Agencies and other academic partners are working to link SARS-CoV-2 genome data with epidemiological, clinical and contact tracing records nationally.
This will help establish a comprehensive national dataset linking viral sequencing with host genomics, immunology, clinical outcomes and risk factors.
The current COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents a major threat to health. The COVID-19 Genomics UK (COG-UK) consortium has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government.
Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and twelve academic partners providing sequencing and analysis capacity. A full list of collaborators can be found here: https://www.cogconsortium.uk/about/
COG-UK was established in March 2020 supported by £20 million funding from the UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, administered by UK Research and Innovation. For more information, visit: https://www.cogconsortium.uk or follow us on Twitter and on our Blog.
The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org
Related blog posts
22 Oct 2020
Sequencing COVID-19 at the Sanger Institute
This photo essay goes behind the scenes of the effort to sequence the genome of the COVID-19 virus at the Wellcome ...
30 Nov 2023
World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone
The Wellcome Sanger Institute sequenced its share of 500,000 whole human genomes, contributing to the world’s largest single set ...
27 Nov 2023
Pocket-sized DNA sequencers track malaria drug resistance in near real-time
A team of scientists working in Ghana have pioneered on-site genomic surveillance to track changes in the malaria parasite, achieving sampling ...